CVS Health Corp (CVS)

CVS (NYSE:Health Services)
$98.16
pos +0.00
+0.00%
Today's Range: 98.04 - 99.86 | CVS Avg Daily Volume: 4,451,300
Last Update: 01/30/15 - 4:01 PM EST
Volume: 0
YTD Performance: 1.92%
Open: $0.00
Previous Close: $100.11
52 Week Range: $64.95 - $101.59
Oustanding Shares: 1,146,383,477
Market Cap: 114,764,449,882
6-Month Chart
TheStreet Ratings Grade for CVS
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 14 14 13 13
Moderate Buy 3 3 3 3
Hold 2 2 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.34 1.34 1.45 1.45
Latest Dividend: 0.35
Latest Dividend Yield: 1.40%
Dividend Ex-Date: 01/20/15
Price Earnings Ratio: 25.87
Price Earnings Comparisons:
CVS Sector Avg. S&P 500
25.87 25.90 25.69
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
14.74% 45.10% 134.16%
GROWTH 12 Mo 3 Yr CAGR
Revenue 2.90 0.31 0.09
Net Income 18.50 0.34 0.10
EPS 23.80 0.50 0.14
Earnings for CVS:
EBITDA 9.91B
Revenue 126.76B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $1.21 $1.08 $4.50 $5.14
Number of Analysts 12 10 14 14
High Estimate $1.24 $1.09 $4.53 $5.20
Low Estimate $1.19 $1.06 $4.48 $5.08
Prior Year $1.12 $1.02 $4.00 $4.50
Growth Rate (Year over Year) 7.59% 5.59% 12.39% 14.41%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

bullishCVS upgraded at Goldman

Jan 21, 2015 | 8:34 AM EST

CVS was upgraded to Buy, Goldman Sachs said. $113 price target. Company can deliver consistent 15% annual earnings growth. 

By

Jim Cramer

 | Jan 21, 2015 | 7:15 AM EST

Two analysts predicted the big rise in Netflix. Well done.

By

Jim Cramer

 | Jan 6, 2015 | 4:05 PM EST

These store-based U.S. retailers are an eclectic mix.

By

Bret Jensen

 | Jan 6, 2015 | 10:30 AM EST

They offer a nice shelter for the headwinds now hitting equities.

By

David Katz

 | Dec 26, 2014 | 12:30 PM EST

Its hepatitis C drug is better; the stock trades at a discount.

By

Jim Cramer

 | Dec 22, 2014 | 2:51 PM EST

And stop chasing stocks that won't let you in.

By

Jim Cramer

 | Dec 22, 2014 | 11:00 AM EST

Let's look at the other groups that caught fire.

By

Paul Price

 | Dec 18, 2014 | 8:30 AM EST

CVS is a healthy company trading at an unhealthy level.

By

Brian Sozzi

 | Dec 17, 2014 | 10:00 AM EST

Do your homework before the meeting.

bullishCVS price target raised at Barclays

Dec 17, 2014 | 7:29 AM EST

CVS price target raised to $107 from $98, said Barclays. Stock is trading at a lower than expected multiple given multi-year EPS growth of 12%, strong free cash flow generation, and disciplined approach to returning cash to shareholders.

Ugly end to a challenging week as stocks post around three percent declines for the openin...
I have scaled further into a TLT short - scaling all the way up to $138.35 this morning. A...
Market slightly down despite the boost Amazon (AMZN) is giving the NASDAQ. Biotech also co...
There are a number of interesting technical signals on the weekly and daily Berkshire Hath...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.